Sector: Medtech
Year of investment: 2017
Founded in 2002, Beijing Medos is a medtech company specialized in cardiac surgery, extracorporeal circulation and intensive care.
Kuanping Capital acquired a majority stake in Beijing Medos in 2017and fully exited the investment by trade sale to a strategic investor in 2021.
Sector: Healthcare Service
Year of Investment: 2016 – present
Kuanping Capital established a strategic partnership with Wenzhou Kangning Hospital Co. Ltd., the largest privately-owned psychiatric hospital group in China and started to acquire privately-owned psychiatric hospitals in 2016. Currently it has acquired and operates 8 psychiatric hospitals in Beijing, Chengdu, Zhejiang, Hunan, Nanjing, etc., with total number of beds of around 2,000 and revenue of approximate 100M RMB. Kuanzhan is the second largest psychiatric hospital group in China。
Sector: Digital Health
Year of investment: 2019
For more information, please visit www.nuanwa.net
Shanghai Nova Technology is China’s leading integrated platform providing comprehensive technical solutions to health insurance companies. It was established in 2018 by Zhong An Technology, a wholly-owned subsidiary of China’s leading internet insurance company Zhong An. Nova Technology commits to provide intelligent health insurance operation platform and tailored insurance products driven by cutting-edge technologies such as big data, artificial intelligence and blockchain. Kuanping Capital participated in the angel round financing of Nova Technology in 2019.
Sector：Medtech
Year of Investment ：2020年
For more information, please visit www.brattea.com
Brattea, a high-tech enterprise focusing on the development and commercialization of neuro-radiofrequency ablation technology and products, was established in 2013. Brattea has successfully deployed the treatment and management for chronic disease by developing an original transvacuolar nerve ablation technology platform. The company has a leading position in the domestic industry while surpassing international peers in the field of Renal Denervation (RDN) technology. In addition to hypertension, RDN has made great progress in tumor analgesia, diabetes, vasculitis, and atrial fibrillation.
Sector：Healthcare Service
Year of Investment ：2020年
For more information, please visit www.linjiahaoyi.com
Founded in 2016, NeighBor Doc is a leading platform which provides comprehensive healthcare service in Hangzhou. The company applied multi-level medical and healthcare services, committed to becoming the largest clinic chain group and the first option in demand for healthcare service in China.